Women's Reproductive Cancers

The gynecologic oncologists at the Cedars-Sinai Center for Women's Reproductive Cancers practice cutting edge, comprehensive, clinical cancer care.

All of the center's physicians are highly skilled in advanced laparoscopic procedures. They offer patients the ability to manage reproductive cancers using minimally invasive surgical procedures. Additionally, the center's physicians are trained in the use of the da Vinci advanced robotic system to treat these diseases.

In the clinic, we apply the most up-to-date treatment regimens, including intraperitoneal chemotherapy and targeted biologic therapeutics.

Research to uncover new and better approaches to treating women's reproductive cancers are a key component of the work at the center. A large number of clinical trials are underway at the center. Physicians and researchers at the center participate in national and international studies including collaborations with the National Cancer Institute's Gynecologic Oncology Group. These efforts bring to our patients relevant, effective, and cutting edge treatments to manage their gynecologic cancers.

Our physicians have expertise in all gynecologic malignancies, including advanced and recurrent ovarian cancers, hereditary gynecologic cancers and fertility-sparing surgery.

Measuring Quality of Care at the Cedars-Sinai Center for Women's Reproductive Cancer

At the Cedars-Sinai Center for Women's Reproductive Cancer, a variety of factors are monitored to measure the quality of care available to patients, including:

• Patient and procedure volumes
• Number of clinical trials
• Average length of stay (ALOS)
  
  

These factors are explained in more detail below.

Patient Volume at the Cedars-Sinai Center for Women's Reproductive Cancer

Over the past three years, the number of new and returning patients at the Cedars-Sinai Center for Women's Reproductive Cancers has steadily increased.

Clinical Trials at the Cedars-Sinai Women's Reproductive Cancers Center of Excellence

Clinical trials are used to evaluate the effectiveness and safety of medications, treatments or medical devices by monitoring their effects on large groups of people. Cedars-Sinai is committed to ongoing research to discover new and more effective treatments.

The tissue bank at the Cedars-Sinai Women's Reproductive Cancers Center of Excellence collects, preserves and studies tissue samples as part of its ongoing research efforts to find new and better treatments for women's reproductive cancers.

Inpatient Procedure Volumes and Average Length of Stay for Patients at the Cedars-Sinai Women's Reproductive Cancers Center of Excellence

Studies have demonstrated that hospitals that regularly perform a particular procedure tend to have better outcomes than those that perform the procedure less frequently.

Average length of stay (ALOS) is another aspect of quality of patient care that is monitored at Cedars-Sinai. This refers to the average number of days a patient stays at Cedars-Sinai Medical Center after being admitted. The goal is to ensure that all patients are appropriately treated in the hospital for their respective conditions, and are not hospitalized longer than they need to be.